Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
3 Magnificent Growth Stocks to Buy in March
10:41am, Saturday, 08'th Mar 2025
It's often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up.
Ongoing Studies are Evaluating Long-Term Maintenance and Durability THOUSAND OAKS, Calif., and TOKYO , March 8, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd.
NVO, LLY and AMGN Forecast – Pharma Stocks Look Mixed in Premarket
10:58am, Friday, 07'th Mar 2025
Three of the major pharma companies that I follow have shown a bit of a mixed move in the premarket hours, as the markets try to get a grip on the latest demand for GLP-1 and other medicines.
2 Dividend Stocks to Buy for a Lifetime of Passive Income
05:03am, Friday, 07'th Mar 2025
Dividend investors don't buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its dividend program, the more attractive it is to income seekers, all
Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 06'th Mar 2025
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amgen Inc. (NASDAQ: AMGN) on be
Trade Tracker: Joe Terranova sells the XBI, buys Amgen
01:28pm, Wednesday, 05'th Mar 2025
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
Amgen Inc. (AMGN) 45th Annual TD Cowen Health Care Conference (Transcript)
11:09am, Wednesday, 05'th Mar 2025
Amgen Inc. (NASDAQ:AMGN ) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ET Company Participants Jay Bradner - Executive Vice President and Head, R&D Justin Claeys - Vice
Amgen starts two critical late-stage trials for weight loss drug MariTide
09:54am, Wednesday, 05'th Mar 2025
Amgen said it has started two critical late-stage trials for its experimental weight loss injection, MariTide, another step in its bid to enter the booming obesity drug market. MariTide is a monthly
AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND
04:54pm, Tuesday, 04'th Mar 2025
THOUSAND OAKS, Calif. , March 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the second quarter of 2025.
Dogs Of The Dow Chase A "Safer" Buy For March
02:56pm, Tuesday, 04'th Mar 2025
Verizon is the only Dow Dog meeting the ideal of dividends from $1K invested exceeding its single share price, making it a 'safer' buy. Analysts project net gains of 13.06% to 37.60% from the top ten
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:00am, Tuesday, 04'th Mar 2025
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Significantly Reduced Nasal Congestion, Polyp Size and Nearly Eliminated Need for Surgery Data Published in NEJM and Presented at AAAAI/WAO 2025 THOUSAND OAKS, Calif. , March 1, 2025 /PRNewswire/ -- A
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
04:01pm, Friday, 28'th Feb 2025
THOUSAND OAKS, Calif. , Feb. 28, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m.
This Could Be the Best GLP-1 Stock to Buy in 2025
08:45am, Friday, 28'th Feb 2025
The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype around weight loss drugs isn't new, but when people are losing more than 20
